• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Connect Biopharma Holdings Limited - Ordinary Shares (NQ:CNTB)

    2.853 +0.033 (+1.17%)
    Streaming Delayed Price Updated: 3:39 PM EDT, Apr 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 366,607
    Open 2.810
    Bid (Size) 2.820 (300)
    Ask (Size) 2.870 (100)
    Prev. Close 2.820
    Today's Range 2.690 - 3.100
    52wk Range 0.6300 - 3.820
    Shares Outstanding 55,041,247
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
    Via ACCESS Newswire
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill

    Performance

    YTD
    +13.2%
    +13.2%
    1 Month
    +6.1%
    +6.1%
    3 Month
    +34.6%
    +34.6%
    6 Month
    +56.8%
    +56.8%
    1 Year
    +338.3%
    +338.3%

    More News

    Read More
    News headline image
    Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma Announces $20.2 Million Private Placement Financing
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Which stocks have an unusual volume on Friday? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESS Newswire
    News headline image
    Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    News headline image
    Connect Biopharma Presents Data Supporting Rademikibart at the European Respiratory Society Congress 2025
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma Announces Two Presentations at the European Respiratory Society (ERS) Congress 2025
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Which stocks are moving before the opening bell on Wednesday? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Connect Biopharma Completes Termination of its American Depositary Receipt Program and Directly Lists its Ordinary Shares on Nasdaq
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma to Present at Two Upcoming Investor Conferences in September
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma Teams with Ickey Woods and the Jovante Woods Foundation to Expand Asthma Education Program Nationwide
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma Posts Q2 Revenue Drop ↗
    Via The Motley Fool
    Topics Intellectual Property

    Frequently Asked Questions

    Is Connect Biopharma Holdings Limited - Ordinary Shares publicly traded?
    Yes, Connect Biopharma Holdings Limited - Ordinary Shares is publicly traded.
    What exchange does Connect Biopharma Holdings Limited - Ordinary Shares trade on?
    Connect Biopharma Holdings Limited - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Connect Biopharma Holdings Limited - Ordinary Shares?
    The ticker symbol for Connect Biopharma Holdings Limited - Ordinary Shares is CNTB on the Nasdaq Stock Market
    What is the current price of Connect Biopharma Holdings Limited - Ordinary Shares?
    The current price of Connect Biopharma Holdings Limited - Ordinary Shares is 2.853
    When was Connect Biopharma Holdings Limited - Ordinary Shares last traded?
    The last trade of Connect Biopharma Holdings Limited - Ordinary Shares was at 04/13/26 03:39 PM ET
    What is the market capitalization of Connect Biopharma Holdings Limited - Ordinary Shares?
    The market capitalization of Connect Biopharma Holdings Limited - Ordinary Shares is 157.03M
    How many shares of Connect Biopharma Holdings Limited - Ordinary Shares are outstanding?
    Connect Biopharma Holdings Limited - Ordinary Shares has 157M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.